Actively Recruiting

Phase Not Applicable
Age: 21Years - 70Years
All Genders
ID06890169

OneSTOP (One-Stop Telehealth Obesity Program): the Use of Telecare and Digital Platforms for Multidisciplinary Management of Weight Management and Related Comorbidities

Led by Changi General Hospital · Updated on 2025-03-21

120

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

C

Changi General Hospital

Lead Sponsor

N

National University of Singapore

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a care model that combines teleconsultations and the EMPOWER app to support weight loss and metabolic improvements in adults who are obese with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD). This study compares this telehealth-based model to the conventional face-to-face weight management program to see if it is at least as effective and whether it offers more convenience and better adherence to diet and exercise routines. The study involves two groups over 26 weeks. One group receives standard care with 4 physical doctor and 4 dietician visits following best-practice guidelines. They get personalized exercise and calorie-deficit diet plans aiming for at least 5% weight loss. The other group, called the OneSTOP program, has at least half of these visits as teleconsults and uses the EMPOWER app to track weight, blood pressure, glucose, food intake, and exercise. The app provides reminders, health information, and helps with more precise calorie counting paired with an activity tracker. Participants will attend scheduled visits, upload their health data via the app if in the intervention group, and keep food and exercise records. Doctors and dieticians will review progress and adjust plans as needed. The main outcome measured is weight loss at 26 weeks, with secondary outcomes including the percentage achieving at least 5% weight loss, improvements in blood sugar control, and MASLD. The total study duration per participant is 26 weeks, with regular monitoring and support throughout.

CONDITIONS

Brief Title

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

Who Can Participate

Age: 21Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 21 to 70 years
  • Body mass index greater than 27.5 kg/m2
  • Waist circumference greater than 90 cm in men or 80 cm in women
  • Suboptimal control of type 2 diabetes (HbA1c over 6.5%) and/or metabolic dysfunction-associated steatotic liver disease (MASLD) confirmed by imaging or biopsy
Not Eligible

You will not qualify if you...

  • Men who drink more than 21 alcohol units per week or women who drink more than 14 units per week
  • Previous use of weight-lowering medications without a minimum 3-month washout period before participation
  • Illness with life expectancy less than 6 months
  • Inability to comply with written instructions in English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 26 weeks

Participants engage in a 26-week weight management program with regular consultations and tailored exercise and dietary plans. The program includes 4 doctor and 4 dietician consults, either face-to-face or via teleconsults, along with support through an exercise prescription and calorie-deficit diet. Participants track their progress using food diaries, exercise records, and, for some, a digital app to monitor health and adherence.

8 visits over 26 weeks (combination of in-person and teleconsults depending on group assignment)

Trial Site Locations

Total: 1 location

1

Changi General Hospital

Singapore, Singapore, 529889

Actively Recruiting

Loading map...

Research Team

J

Joan Khoo, MBBS, FRCP

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

"Smart Family Doctor" Assisted Comprehensive Management of S...

Post Coronary Artery Bypass Grafting

Actively Recruiting

1 location

The PILI 'Aina Project to Improve Cardiometabolic Health in...

Type 2 Diabetes

Actively Recruiting

2 locations

Vascular Function in Health and Disease: Rehabilitation for ...

Chronic Obstructive Pulmonary Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

OneSTOP (One-Stop Telehealth Obesity Program): study protocol for an open-label randomized controlled trial on the use of telecare and digital platforms for multidisciplinary management of weight management and related comorbidities.

Joan Khoo, Ang Tiing Leong, Kumar Rahul...

https://pubmed.ncbi.nlm.nih.gov/41877269